
Cilnidipine (10mg) + Metoprolol Succinate (50mg)
Active composition
+1 more active ingredient
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Natcocil-M Tablet ER is a combined antihypertensive medication containing Cilnidipine 10mg and Metoprolol Succinate 50mg. This extended-release formulation is designed for once-daily administration. Cilnidipine, a dihydropyridine calcium channel blocker, acts by relaxing peripheral arteries, reducing vascular resistance, and lowering blood pressure. Metoprolol Succinate, a selective beta-1 adrenoreceptor blocker, decreases the heart rate and cardiac output, further contributing to blood pressure reduction. The co-administration of these two drugs provides a comprehensive approach to managing hypertension, offering potential benefits in terms of improved cardiovascular outcomes. It is essential to follow the prescribed dosage and monitoring guidelines, as with any medication, to ensure safe and effective use of Natcocil-M Tablet ER.
How to use Natcocil-M Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Natcocil-M Tablet ER is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Natcocil-M Tablet ER.
High Risk
Natcocil-M Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Natcocil-M Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Natcocil-M Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Natcocil-M Tablet ER may be needed. Please consult your doctor.
Regular Checkup
Information regarding the use of Natcocil-M Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Natcocil-M Tablet ER in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Natcocil-M Tablet ER

Cilnidipine (10mg) + Metoprolol Succinate (50mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medical applications
Natcocil-M Tablet ER is a combined antihypertensive medication containing Cilnidipine 10mg and Metoprolol Succinate 50mg. This extended-release formulation is designed for once-daily administration. Cilnidipine, a dihydropyridine calcium channel blocker, acts by relaxing peripheral arteries, reducing vascular resistance, and lowering blood pressure. Metoprolol Succinate, a selective beta-1 adrenoreceptor blocker, decreases the heart rate and cardiac output, further contributing to blood pressure reduction. The co-administration of these two drugs provides a comprehensive approach to managing hypertension, offering potential benefits in terms of improved cardiovascular outcomes. It is essential to follow the prescribed dosage and monitoring guidelines, as with any medication, to ensure safe and effective use of Natcocil-M Tablet ER.
How to use Natcocil-M Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Natcocil-M Tablet ER is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Natcocil-M Tablet ER.
High Risk
Natcocil-M Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Natcocil-M Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Natcocil-M Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Natcocil-M Tablet ER may be needed. Please consult your doctor.
Regular Checkup
Information regarding the use of Natcocil-M Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Natcocil-M Tablet ER in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Natcocil-M Tablet ER















